About Us
About Us
About Us
About Us
NewValvePatients was founded for one reason - to accelerate new patient acquisition for cardiac centers and medical companies that specialize in heart valve disease. Our proprietary and cloud-based technologies are used by Top 10 cardiac centers and multi-national companies that offer services, products and solutions for commercially-available heart valve therapies. In addition, we have a novel patient recruitment platform that accelerates patient enrollment in heart valve clinical trials.
Our company was started by Adam Pick, a leading digital and healthcare evangelist who is followed by 325,000 people across social media. Adam has been featured by The Wall Street Journal, BusinessWeek and the American Heart Association for his unique perspectives and technologies that address and solve many of the challenges within healthcare today. Over 200 clinicians, hospitals, medical companies, marketing agencies and research organizations deploy the next-generation services developed by Adam and our passionate team.
The NewValvePatients team is guided by a “Patients Now! Patients First!” mission. The functional roles of our global team includes:
- Call center administrators
- Customer relationship management (CRM) system administrators
- HIPAA & security experts
- Legal specialists
- Media architects
- Patient interface (PX) scientists
- Patient relationship management (PRM) coders
- Patient advocates
- Program managers
- Search engine experts (Google, YouTube, Bing)
- Social media experts (Facebook, Twitter, LinkedIn)
- Web developers (HTML5, PHP, MySQL, JS, JQuery)
- Video production and editing crew
To learn more, we encourage you to download our case studies, see our client testimonials or schedule a live demonstration.
NewValvePatients was founded for one reason - to accelerate new patient acquisition for cardiac centers and medical companies that specialize in heart valve disease. Our proprietary and cloud-based technologies are used by Top 10 cardiac centers and multi-national companies that offer services, products and solutions for commercially-available heart valve therapies. In addition, we have a novel patient recruitment platform that accelerates patient enrollment in heart valve clinical trials.
Our company was started by Adam Pick, a leading digital and healthcare evangelist who is followed by 325,000 people across social media. Adam has been featured by The Wall Street Journal, BusinessWeek and the American Heart Association for his unique perspectives and technologies that address and solve many of the challenges within healthcare today. Over 200 clinicians, hospitals, medical companies, marketing agencies and research organizations deploy the next-generation services developed by Adam and our passionate team.
The NewValvePatients team is guided by a “Patients Now! Patients First!” mission. The functional roles of our global team includes:
- Call center administrators
- Customer relationship management (CRM) system administrators
- HIPAA & security experts
- Legal specialists
- Media architects
- Patient interface (PX) scientists
- Patient relationship management (PRM) coders
- Patient advocates
- Program managers
- Search engine experts (Google, YouTube, Bing)
- Social media experts (Facebook, Twitter, LinkedIn)
- Web developers (HTML5, PHP, MySQL, JS, JQuery)
- Video production and editing crew
To learn more, we encourage you to download our case studies, see our client testimonials or schedule a live demonstration.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our novel
approach to new patient acquisition.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our
novel approach to new
patient acquisition.
Unlike other digital agencies, our team focuses solely on
new patient acquisition for atrial fibrillation. During the
past 5 years, we have acquired over 7,000 patients for
commercial AFib therapies (cardioversion, ablation,
Watchman, Maze procedure) or clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 5 years, we have acquired over 7,000 patients for commercial AFib therapies (cardioversion, ablation, Watchman, Maze procedure) or clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for heart valve disease. During the past 4 years, we have generated over 3,000 patient inquiries for commercial heart valve therapies and clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 5 years, we have acquired over 7,000 patients for commercial AFib therapies (cardioversion, ablation, Watchman, Maze procedure) or clinical trials.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our
novel approach to new
patient acquisition.
Unlike other digital agencies, our team focuses solely on new
patient acquisition for heart valve disease. During the past
4 years, we have generated over 3,000 patient inquiries
for
commercial heart valve therapies and clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for heart valve disease. During the past 4 years, we have generated over 3,000 patient inquiries for commercial heart valve therapies and clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 5 years, we have acquired over 7,000 patients for commercial AFib therapies (cardioversion, ablation, Watchman, Maze procedure) or clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for heart valve disease. During the past 4 years, we have generated over 3,000 patient inquiries for commercial heart valve therapies and clinical trials.
